Soref, Cheryl M <br/><br/>
A new orally active, aminothiol radioprotector-free of nausea and hypotension side effects at its highest radioprotective doses.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Apr 2012 
 - e701-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2011.11.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Amifostine--administration & dosage<br/>Animals<br/>Diamines--administration & dosage<br/>Drug Evaluation, Preclinical<br/>Female<br/>Ferrets<br/>Hypotension--chemically induced<br/>Infusions, Intra-Arterial<br/>Infusions, Parenteral<br/>Injections, Subcutaneous<br/>Male<br/>Maximum Tolerated Dose<br/>Mice<br/>Mice, Inbred ICR<br/>Nausea--chemically induced<br/>Radiation Injuries, Experimental--prevention & control<br/>Radiation-Protective Agents--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sulfhydryl Compounds--administration & dosage<br/>Vomiting--chemically induced